Marvel Secures Funding for Pediatric Liquid MB-204
Child-Friendly MB-204 Formulation Targets Neuro Disorders – February 18, 2026 | Calgary, Alberta Marvel Biosciences Corp. has secured advisory...
GMP
Advertisement
RSV Vaccine Data Show Reduced Cardio-Respiratory Risks
Real-World Evidence Strengthens Adult Prevention Impact February 17, 2026 | London, United Kingdom GSK has released new real-world effectiveness...
EU Clears ANKTIVA–BCG for Bladder Cancer Therapy
Conditional Approval Expands Access to 33 Countries February 18, 2026 | Culver City, California ImmunityBio announced that the European...
Elanco Sets Date for Q4 and Full-Year 2025 Results Call
Indianapolis, USA | January 22, 2026 — Elanco Animal Health, a global leader in veterinary pharmaceuticals and animal health...
FDA Recall Highlights cGxP Failures at Gold Star Facility
MINNEAPOLIS, December 26, 2025 — Gold Star Distribution, Inc. has issued a sweeping recall of all FDA-regulated products stored...
Advertisements
Leadership Shift at Vetter Signals New Phase in Global GMP Manufacturing Strategy
Ravensburg, Germany — December 3, 2025 — Vetter Pharma-Fertigung GmbH & Co. KG, a global contract development and manufacturing...
Barilla Revives Snowfall Pasta to Celebrate the Cozy Food Season
Dateline — NORTHBROOK, Ill., November 10, 2025:Barilla America, Inc., the world’s leading pasta maker, has declared pasta the official...
MSD Animal Health Data Confirms Efficacy of Intranasal Bovine Coronavirus Vaccine
BOXMEER, The Netherlands — October 23, 2025 — MSD Animal Health, a global leader in veterinary biopharmaceutical innovation, announced...
CS Diagnostics Strengthens Financial Structure Through Share Conversion
NEW YORK, November 3, 2025 — CS Interpharm and CS Diagnostics Pharma (CSDX) have announced the completion of a...
AbbVie Raises 2025 Outlook as Skyrizi and Rinvoq Surge
NORTH CHICAGO, Ill., November 2, 2025 — AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical leader, has raised its annual...
Advertisement
